Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy-Reference-Cited by-同舟云学术

Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy

Published:2014-10-18 Issue:1 Volume:71 Page:51-58
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Hashi Sachiyo,Yano Ikuko,Shibata Mai,Masuda Satohiro,Kinoshita Masako,Matsumoto Riki,Ikeda Akio,Takahashi Ryosuke,Matsubara Kazuo

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-014-1773-z.pdf

Reference33 articles.

1. Ng YT, Collins SD (2007) Clobazam. Neurotherapeutics 4:138–144

2. Shorvon SD (1995) Benzodiazepines: clobazam. In: Levy RH, Mattson RH, Meldrum BS (eds) Antiepileptic drugs, 4th edn. Raven Press Ltd, New York, pp 763–777

3. Dichter MA, Brodie MJ (1996) New antiepileptic drugs. N Engl J Med 334:1583–1590

4. de Leon J, Spina E, Diaz FJ (2013) Clobazam therapeutic drug monitoring: a comprehensive review of the literature with proposals to improve future studies. Ther Drug Monit 35:30–47

5. Canadian Clobazam Cooperative Group (1991) Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Epilepsia 32:407–416

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy;Genes;2023-05-16

2. Personalized antiseizure medication therapy in critically ill adult patients;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-04-09

3. Use of pharmacogenetics for benzodiazepine prescription: state of the art and expectations;Pharmacogenomics;2022-12

4. Role of pharmacogenomics for prediction of personalized medicines;Biochemistry of Drug Metabolizing Enzymes;2022

5. Index;Medication-Resistant Epilepsy;2020-08-31